Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Tang

Showing results (111-120 of 1,043) with videos related to

Pageof 105
Sort By:
Journal of the American College of Cardiology|December 19, 2006
The year in heart failureW H Wilson Tang, Gary S Francis
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for acute and chronic heart failure: current and future developmentsStephen Y Chen, W H Wilson Tang
Medgenmed : Medscape General Medicine|August 24, 2006
Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurementsRobert H Christenson, W H Wilson Tang
The Journal of Cardiovascular Aging|July 27, 2022
Gut microbiota in sarcopenia and heart failureChia-Feng Liu, W H Wilson Tang
Journal of Cardiac Failure|May 13, 2026
A Pragmatic Approach to Acute Myocarditis in the Era of Advanced Diagnostics: From Diagnostic Certainty to Risk-Based CareW H Wilson Tang, Leslie T Cooper
Journal of the American College of Cardiology|October 8, 2016
Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney DiseaseW H Wilson Tang, Stanley L Hazen
Heart Failure Reviews|February 18, 2014
Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseasesAdam Mohmand-Borkowski, W H Wilson Tang
JACC. Heart Failure|May 9, 2015
Worsening heart failure: challenges as a therapeutic targetW H Wilson Tang, Justin L Grodin
Current Treatment Options in Cardiovascular Medicine|March 23, 2015
Contribution of environmental toxins in the pathogenesis of idiopathic cardiomyopathiesAntonio L Perez, W H Wilson Tang
Circulation|January 19, 2011
Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary noteW H Wilson Tang, Gary S Francis
Pageof 105

Showing results (111-120 of 1,043) with videos related to

Sort By:
Pageof 105
Journal of the American College of Cardiology|December 19, 2006
The year in heart failureW H Wilson Tang, Gary S Francis
Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for acute and chronic heart failure: current and future developmentsStephen Y Chen, W H Wilson Tang
Medgenmed : Medscape General Medicine|August 24, 2006
Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurementsRobert H Christenson, W H Wilson Tang
The Journal of Cardiovascular Aging|July 27, 2022
Gut microbiota in sarcopenia and heart failureChia-Feng Liu, W H Wilson Tang
Journal of Cardiac Failure|May 13, 2026
A Pragmatic Approach to Acute Myocarditis in the Era of Advanced Diagnostics: From Diagnostic Certainty to Risk-Based CareW H Wilson Tang, Leslie T Cooper
Journal of the American College of Cardiology|October 8, 2016
Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney DiseaseW H Wilson Tang, Stanley L Hazen
Heart Failure Reviews|February 18, 2014
Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseasesAdam Mohmand-Borkowski, W H Wilson Tang
JACC. Heart Failure|May 9, 2015
Worsening heart failure: challenges as a therapeutic targetW H Wilson Tang, Justin L Grodin
Current Treatment Options in Cardiovascular Medicine|March 23, 2015
Contribution of environmental toxins in the pathogenesis of idiopathic cardiomyopathiesAntonio L Perez, W H Wilson Tang
Circulation|January 19, 2011
Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary noteW H Wilson Tang, Gary S Francis
Pageof 105